Viewing Study NCT01693120


Ignite Creation Date: 2025-12-25 @ 4:24 AM
Ignite Modification Date: 2026-03-12 @ 10:42 AM
Study NCT ID: NCT01693120
Status: TERMINATED
Last Update Posted: 2025-02-13
First Post: 2012-09-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluation of the Phased Radio Frequency Ablation System
Sponsor: Medtronic Cardiac Ablation Solutions
Organization:

Study Overview

Official Title: Evaluation of Multielectrode Phased RF Technology in Persistent Atrial Fibrillation
Status: TERMINATED
Status Verified Date: 2025-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: The study was stopped solely based on lower than expected enrollment rate.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: VICTORY-AF
Brief Summary: VICTORY AF is an IDE, prospective global, multi-center, single arm, controlled, unblinded, investigational clinical study. The purpose of this clinical study is to evaluate the risk of procedure and/or device related strokes in subjects with persistent or long-standing persistent atrial fibrillation (AF) undergoing ablation with the Phased RF System.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: